← Leaderboards
Jennifer A. Doherty
Fred Hutchinson Cancer Research Center
$9,064,784
Attributed
$19,139,161
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,139,161 · 7
By mechanism
R01$19,066,260 · 6
N02$72,901 · 1
Top collaborators
- Elisa V Bandera9 shared
- Scarlett L Gomez9 shared
- Lawrence H Kushi9 shared
- Casey S Greene6 shared
- Joellen M. Schildkraut6 shared
- Mary Anne Rossing4 shared
- Mia Hashibe2 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Amanda G Paulovich$38,180,578
- Mary Anne Rossing$9,127,835
- Anne M McTiernan$13,216,472
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsReportingTumorWomanCancer EtiologyMalignant Neoplasm Of OvaryCessation Of LifeEpithelial Ovarian CancerMolecularSerousGene ExpressionCellsBiologicalUnited StatesMolecular SubtypesSamplingGeneticCancer SubtypesCohortCancer DiagnosisRaceBasePatternDiagnosis
Grant awards (32)
Identifying Multilevel Drivers of Differences in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,067,936
R01 · FY2025 · CA · contact PI
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry$648,152
R01 · FY2025 · CA · contact PI
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry$618,197
R01 · FY2024 · CA · contact PI
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling$469,080
R01 · FY2024 · CA
NCI PATTERNS OF CARE STUDY FOR DIAGNOSIS YEAR 2021 (PROSTATE CANCER AND OVARIAN CANCER)$72,901
N02 · FY2024 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1
R01 · FY2024 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,365,470
R01 · FY2023 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$100,833
R01 · FY2023 · CA · contact PI
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling$79,490
R01 · FY2023 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,445,236
R01 · FY2022 · CA · contact PI
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling$573,258
R01 · FY2022 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$199,995
R01 · FY2022 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$102,222
R01 · FY2022 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,386,624
R01 · FY2021 · CA · contact PI
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling$598,647
R01 · FY2021 · CA
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women$550,732
R01 · FY2021 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,371,104
R01 · FY2020 · CA · contact PI
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling$595,702
R01 · FY2020 · CA
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women$560,285
R01 · FY2020 · CA · contact PI
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling$649,725
R01 · FY2019 · CA
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women$550,804
R01 · FY2019 · CA · contact PI
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women$557,804
R01 · FY2018 · CA · contact PI
Epidemiologic factors and survival by molecular subtypes of ovarian cancer$654,304
R01 · FY2016 · CA
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women$555,727
R01 · FY2016 · CA · contact PI
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women$21,432
R01 · FY2016 · CA · contact PI
Epidemiologic factors and survival by molecular subtypes of ovarian cancer$621,252
R01 · FY2015 · CA
Epidemiologic factors and survival by molecular subtypes of ovarian cancer$602,370
R01 · FY2014 · CA
Telomeres and lung cancer incidence and survival$479,954
R01 · FY2014 · CA · contact PI
Epidemiologic factors and survival by molecular subtypes of ovarian cancer$682,662
R01 · FY2013 · CA
Telomeres and lung cancer incidence and survival$528,941
R01 · FY2013 · CA · contact PI
Telomeres and lung cancer incidence and survival$703,025
R01 · FY2012 · CA · contact PI
Telomeres and lung cancer incidence and survival$725,296
R01 · FY2011 · CA · contact PI